Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 CHF | +0.34% | +7.27% | +43.90% |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Apr. 17 | Swiss Court OKs Moratorium Extension for Spexis | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 0.0650 | 0.5500 | 0.4200 |
Spread/Res. | -9.23% | -89.27% | -85.95% |
Spread/Supp. | +14.34% | +76.65% | +73.53% |
Support | 0.0516 | 0.0334 | 0.0340 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- POLN Stock
- Charts Spexis AG